Superworth

Large drugmakers cheapest against their own PE history

Where today's PE sits among every trading day of the company's last ten years: 0 is its cheapest day, 100 its dearest. As of .

Ranked
17
of 411 large drugmakers we cover
Median
41st pct
Lowest
0th pct
ANIP
Range
0th pct to 100th pct
median 41st pct
0th pct100th pct
#CompanyPE vs its 10 yearsPEIts 10y median PEMarket cap
1ANIPANI Pharmaceuticals0th pct15.0×57.5×$1.6B
2NATRNatures Sunshine Products5th pct11.9×20.2×$211.5M
3BMYBristol-Myers Squibb12th pct14.0×19.9×$128.7B
4JAZZJazz Pharmaceuticals16th pct14.7×20.1×$13.9B
5PAHCPhibro Animal Health19th pct15.9×21.5×$1.6B
6AMPHAmphastar Pharmaceuticals31st pct15.9×20.5×$1.1B
7LFVNLifevantage31st pct14.7×19.4×$73.5M
8PBHPrestige Consumer Healthcare32nd pct13.9×15.3×$2.4B
9LGNDLigand Pharmaceuticals41st pct32.7×37.6×$6.1B
10LLYEli Lilly and55th pct46.5×41.6×$1.3T
11ABBVAbbVie74th pct49.8×27.9×$511.6B
12AMGNAmgen80th pct29.0×21.2×$252.3B
13JNJJohnson & Johnson90th pct40.9×24.3×$650.2B
14CORTCorcept Therapeutics93rd pct192×28.3×$8.7B
15PFEPfizer98th pct40.6×15.8×$176B
16BIIBBiogen99th pct44.3×16.2×$37B
17MRKMerck100th pct150×25.0×$359.5B

Not ranked: 326 with no PE (losses over the last year), 15 with under ten years of history. 53 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

PE vs its 10 years for other groups

Other rankings of large drugmakers

The group